about
Superior pattern processing is the essence of the evolved human brainAntidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 yearsEpigenetic Mechanisms of Serotonin Signaling.Current approaches for the discovery of drugs that deter substance and drug abuse.PsychedelicsManganese-enhanced magnetic resonance imaging reveals increased DOI-induced brain activity in a mouse model of schizophrenia.The effect of psilocin on memory acquisition, retrieval, and consolidation in the ratEfavirenz modulation of sleep spindles and sleep spectral profile.Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophreniaThe serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxiety-like behavior and sociabilityPerspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds.Anxiolytic drug discovery: what are the novel approaches and how can we improve them?Effect of a hallucinogenic serotonin 5-HT2A receptor agonist on visually guided, hippocampal-dependent spatial cognition in C57BL/6J mice.Genie in a blotter: A comparative study of LSD and LSD analogues' effects and user profile.Phenomenology, Structure, and Dynamic of Psychedelic States.Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice.Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia.Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMTWhat's old is new.Family a GPCR heteromers in animal models.Controlled substances and innovation of biomedicine: a preclinical perspective.Immunological effects of ayahuasca in humans.Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies.
P2860
Q21972817-4CABF494-6D47-44E1-875C-E0B97925EB0BQ26746137-12B5B298-0471-40FC-9436-80361145C7E4Q27027985-C0613759-545D-4916-989E-0E58EBF99359Q28973615-57D05786-BCA6-42E9-AC39-0C7B5ADB3B7DQ30359998-1C211C22-0466-40D1-9A8B-91C2C2286B4AQ30581184-30D62CCD-E6D2-44E1-87C1-DAB6115B4CEFQ33658155-5AF22BEF-3026-4456-AB9C-ECBCE149C8B5Q34433247-4BB80388-D765-429D-BE9D-121477B98072Q34497649-705F0EAA-1917-4FBE-9542-F12EF53164D5Q34508675-DE315FB6-4FFF-4A62-AD35-0C9B3851C81EQ34546304-F76AC6BA-BE29-4CDD-95EC-1D9A9AA8A1CAQ36023651-10428D8A-6736-40BB-AC29-C94C9624AF2BQ37113859-0EF6B007-ADBF-459D-8BAB-F377D90F7A37Q38160918-D84464BD-3B24-4535-B2F2-9F945F5B7A90Q38433366-F9595C38-7FB8-4DDC-9D22-5BE2C7DFE1DCQ38682464-70BC1EEB-1787-4100-A9F4-B484213D731AQ39057372-41CDBE15-74AA-40BC-A5AD-D6DB91957751Q39414464-B7ED3DF5-690C-4973-B8FE-23CE4FE3CCE5Q40631159-A8FA0AAF-C4DD-4EE0-9D7C-98EA514B0F45Q41860875-6CEAEB6B-DD07-40A0-A5B3-009958823E8DQ42373861-52BDA5CA-4660-4674-8539-6692CA5D570AQ42772045-CE8695AA-517C-442B-8FD2-F6CAA0437940Q42936926-BFA83266-8F2E-4585-9EE1-941A09578CBAQ43794099-E71ECDA7-4E1A-4D5A-8E0B-46A9254F6257Q46150298-2D6879FD-5917-4FD8-99AC-E9F4AE4ED223Q48301733-F21E76DD-7E0C-4E28-A1AC-A5198E2720F2
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Animal models of serotonergic psychedelics.
@ast
Animal models of serotonergic psychedelics.
@en
type
label
Animal models of serotonergic psychedelics.
@ast
Animal models of serotonergic psychedelics.
@en
prefLabel
Animal models of serotonergic psychedelics.
@ast
Animal models of serotonergic psychedelics.
@en
P2860
P356
P1476
Animal models of serotonergic psychedelics.
@en
P2093
James B Hanks
Javier González-Maeso
P2860
P356
10.1021/CN300138M
P577
2012-09-24T00:00:00Z